Extemporaneous ophthalmic preparations. (2020)

• Record Type: Book
• Further Information: Note: Eman Ali Saeed Alghamdi, Abdulmalik Yahya Al Qahtani, Mazen M. Sinjab, Khalid Mohammed Alyahya.
• Other Names: Alghamdi, Eman Ali Saeed; Al Qahtani, Abdulmalik Yahya; Sinjab, Mazen M; Alyahya, Khalid Mohammed
• Contents: Intro -- Preface -- Abstract -- Acknowledgment -- Contents -- About the Authors -- Abbreviations -- Part I -- Chapter 1: Ocular Pharmacokinetics -- References -- Chapter 2: Factors Affecting Bioavailability and Efficacy of Topical Ophthalmic Preparations -- References -- Chapter 3: Ideal Characteristics of Ophthalmic Drug Delivery System -- References -- Chapter 4: Inactive Ingredients Used in the Preparation of Ophthalmic Products -- References -- Chapter 5: Preservatives Used in Ophthalmic Preparations -- Reference -- Part II -- Chapter 6: Topical Ophthalmic Drug Forms -- References Chapter 7: Extemporaneous Compounding of Ophthalmic Products -- Reference -- Chapter 8: Guidelines of The American Society of Health-System Pharmacists (ASHP) on Pharmacy-Prepared Ophthalmic Products -- Reference -- Chapter 9: Formulations of Extemporaneous Topical Ophthalmic Preparations -- 9.1 Acetylcysteine Ophthalmic Solution [1-4] -- 9.2 Amikacin Ophthalmic Solution [5, 6] -- 9.3 Amphotericin B Ophthalmic Solution [7-12] -- 9.4 Atropine Ophthalmic Solution [13-15] -- 9.5 Autologous Serum Ophthalmic Solution [16-22] -- 9.6 Bacitracin Ophthalmic Solution [15, 23] 9.7 Cefazolin Sodium Ophthalmic Solution [15, 24-29] -- 9.8 Ceftazidime Ophthalmic Solution [15, 24, 30-33] -- 9.9 Cefuroxime Ophthalmic Solution [15, 34, 35] -- 9.10 Ceftriaxone Ophthalmic Solution [36, 37] -- 9.11 Clindamycin Ophthalmic Solution [38] -- 9.12 Cyclosporine Ophthalmic Solution [39-49] -- 9.13 Colistimetate Ophthalmic Solution [50-54] -- 9.14 Edetate Disodium Ophthalmic Solution [15, 55-58] -- 9.15 5-Fluorouracil Ophthalmic Solution [59-65] -- 9.16 Gentamicin Ophthalmic Solution [38, 66, 67] -- 9.17 Interferon Alfa-2b Ophthalmic Solution [68-80] 9.18 Medroxyprogesterone Ophthalmic Solution [81-83] -- 9.19 Mitomycin-C Ophthalmic Solution [84-100] -- 9.20 Penicillin G Potassium Ophthalmic Solution [84, 85, 101] -- 9.21 Tacrolimus Ophthalmic Solution [102, 103] -- 9.22 Tobramycin Ophthalmic Solution [84, 85, 104] -- 9.23 Vancomycin Hydrochloride Ophthalmic Solution [38, 105-107] -- 9.24 Voriconazole Ophthalmic Solution [108-118] -- References -- Part III -- Chapter 10: Intravitreal Injections -- References -- Chapter 11: Intracameral Injections -- Reference -- Chapter 12: Formulations of Extemporaneous Intraocular Injections 12.1 Amikacin Sulfate Intravitreal Injection [1] -- 12.2 Amphotericin B Intravitreal Injection [2-6] -- 12.3 Bevacizumab Intravitreal Injection [7-12] -- 12.4 Cefazolin Sodium Intravitreal Injection [3, 13] -- 12.5 Ceftazidime Intravitreal Injection [3, 13, 14] -- 12.6 Cefuroxime Intracameral Injection [15] -- 12.7 Cidofovir Intravitreal Solution [16] -- 12.8 Clindamycin Intravitreal Injection [17-20] -- 12.9 Dexamethasone Phosphate Intravitreal Injection [21] -- 12.10 Foscarnet Intravitreal Injection [22-24] -- 12.11 Ganciclovir Intravitreal Injection [22, 25, 26]
• Publisher Details: Cham : Springer
• Publication Date: 2020
• Extent: 1 online resource (116 pages)
• Subjects: 617.7/061; Ophthalmic drugs; Therapeutics, Ophthalmological; Ophthalmic drugs; Therapeutics, Ophthalmological; Electronic books
• Languages: English
• ISBNs: 9783030274924; 3030274926
• Related ISBNs: 9783030274917
• Notes: Note: Includes bibliographical references and index.; Note: Print version record.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.